These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1478260)

  • 21. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.
    Jutkiewicz EM; Torregrossa MM; Sobczyk-Kojiro K; Mosberg HI; Folk JE; Rice KC; Watson SJ; Woods JH
    Eur J Pharmacol; 2006 Feb; 531(1-3):151-9. PubMed ID: 16442521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.
    Noble F; Benturquia N; Bilkei-Gorzo A; Zimmer A; Roques BP
    Psychopharmacology (Berl); 2008 Feb; 196(2):327-35. PubMed ID: 17906961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RB101-mediated protection of endogenous opioids: potential therapeutic utility?
    Jutkiewicz EM
    CNS Drug Rev; 2007; 13(2):192-205. PubMed ID: 17627672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine.
    Noble F; Roques BP
    Neurosci Lett; 1995 Feb; 185(2):75-8. PubMed ID: 7746508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
    Sofuoglu M; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa.
    Matsumoto K; Horie S; Takayama H; Ishikawa H; Aimi N; Ponglux D; Murayama T; Watanabe K
    Life Sci; 2005 Nov; 78(1):2-7. PubMed ID: 16169018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
    Malmberg AB; Yaksh TL
    J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
    Maldonado R; Valverde O; Ducos B; Blommaert AG; Fournie-Zaluski MC; Roques BP
    Br J Pharmacol; 1995 Mar; 114(5):1031-9. PubMed ID: 7780637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding.
    Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP
    Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids.
    Valverde O; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1996 Sep; 312(1):15-25. PubMed ID: 8891574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
    Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH
    Eur J Pharmacol; 1992 May; 216(1):97-101. PubMed ID: 1326441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
    Le Guen S; Honoré P; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM
    Brain Res; 1999 Jul; 834(1-2):200-6. PubMed ID: 10407116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation.
    Baamonde A; Daugé V; Ruiz-Gayo M; Fulga IG; Turcaud S; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1992 Jun; 216(2):157-66. PubMed ID: 1327810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
    Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.